Oxycodone overdose causes naloxone responsive COMA and QT prolongation

QJM: An International Journal of Medicine

Volumn 106, Issue 1, 2013, Pages 35-41

  Berling, I ^a   Whyte, I M ^a   Isbister, G K ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; AMITRIPTYLINE; BENZODIAZEPINE; DIAZEPAM; DOXYLAMINE; GLUCOSE; IBUPROFEN; INSULIN; NALOXONE; OXYCODONE; RECREATIONAL DRUG;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; CARDIOVASCULAR EFFECT; CLINICAL FEATURE; COMA; DRUG INTOXICATION; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMAN; HYPOTENSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QRS COMPLEX; QT PROLONGATION; RETROSPECTIVE STUDY;

EID: 84871555615     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcs176     Document Type: Article

References (25)

1. Davis MP, Varga J, Dickerson D, Walsh D, LeGrand SB, Lagman R. Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy. Support Care Cancer 2003; 11:84-92.
2. Aquina CT, Marques-Baptista A, Bridgeman P, Merlin MA. OxyContin abuse and overdose. Postgrad Med 2009; 121:163-7.
3. Curtis GB, Johnson GH, Clark P, Taylor R, Brown J, O'Callaghan R, et al. Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model. Eur J Clin Pharmacol 1999; 55:425-9.
4. Baranchuk A, Simpson CS, Methot M, Gibson K, Strum D. Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines. Can J Cardiol 2008; 24:e38-40.
5. Charatan F. Time-release analgesic drug causes fatal overdoses in United States. West J Med 2001; 175:82.
6. Cone EJ, Fant RV, Rohay JM, Caplan YH, Ballina M, Reder RF, et al. Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. J Anal Toxicol 2003; 27:57-67; discussion.
7. Darke S. Oxycodone poisoning: not just the 'usual suspects'. Addiction 2011; 106:1035-6.
8. Darke S, Duflou J, Torok M. Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999-2008. J Forensic Sci 2011; 56:690-3.
9. Drummer OH, Syrjanen ML, Phelan M, Cordner SM. A study of deaths involving oxycodone. J Forensic Sci 1994; 39:1069-75.
10. Schneir AB, Vadeboncoeur TF, Offerman SR, Barry JD, Ly BT, Williams SR, et al. Massive OxyContin ingestion refractory to naloxone therapy. Ann Emerg Med 2002; 40:425-8.
11. Thompson JG, Vanderwerf S, Seningen J, Carr M, Kloss J, Apple FS. Free oxycodone concentrations in 67 postmortem cases from the Hennepin County medical examiner's office.J Anal Toxicol 2008; 32:673-9.
12. Department of Health and Ageing, Australian Government. Oxycodone PBS 2012. http://pbs.gov.au/medicine/item/2622B-5190E-5191F-5195K-5197M-8385H-8386J-8387K-8388L-8464L-8501K-8502L-8644Y-8681X-9399Q-9400R (16 March 2012, date last accessed).
13. Bergdahl IA, Jarvholm B. Cancer morbidity in Swedish asphalt workers. Am J Ind Med 2003; 43:104-8.
14. Berger A. Marijuana has potential for misuse. Br Med J 2000; 321:979.
15. Berger CW Jr, Sultatos LG. The effects of the phosphorothioate insecticide fenitrothion on mammalian cytochrome P450-dependent metabolism of estradiol. Fundam Appl Toxicol 1997; 37:150-7.
16. World Health Organisation. Cancer Pain Relief with a Guide to Opioid Availability. 2nd edn. Geneva, WHO, 1996.
17. Hall WD, Farrell MP. Minimising the misuse of oxycodone and other pharmaceutical opioids in Australia. Med J Aust 2011; 195:248-9.
18. Roxburgh A, Bruno R, Larance B, Burns L. Prescription of opioid analgesics and related harms in Australia. Med J Aust 2011; 195:280-4.
19. Harrison CM, Charles J, Henderson J, Britt H. Opioid prescribing in Australian general practice. Med J Aust 2012; 196:380-1.
20. Green JL, Thomas SHL, Thompson JP, Kupferschmidt H, Desel H, Gunja N, et al. International perspective of prescription opioid exposures reported to poison centres from 2007-2010. Clin Toxicol 2012; 50:1.
21. Fanoe S, Jensen GB, Sjogren P, Korsgaard MP, Grunnet M. Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro. Br J Clin Pharmacol 2009; 67:172-9.
22. Chan A, Isbister GK, Kirkpatrick CM, Dufful SB. Druginduced QT prolongation and torsades de pointes: evaluation of a QT nomogram. QJM 2007; 100:609-15.
23. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17:857-72.
24. Friberg LE, Isbister GK, Hackett LP, Duffull SB. The population pharmacokinetics of citalopram after deliberate selfpoisoning: a Bayesian approach. J Pharmacokinet Pharmacodyn 2005; 32:571-605.
25. Isbister GK, Friberg LE, Hackett LP, Duffull SB. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal. Clin Pharmacol Ther 2007; 81:821-7.